Skip to main content
. Author manuscript; available in PMC: 2009 May 16.
Published in final edited form as: Neuropharmacology. 2008 May 16:nihpa51859. doi: 10.1016/j.neuropharm.2008.05.008

Figure 4.

Figure 4

H3 receptor ligand-mediated modulation of D2 receptor agonist binding in sheep striatal membranes. (A and C) Competition experiments of the D2 receptor antagonist [3H] YM-09151-2 (1.4 nM) versus increasing concentrations of the D2 receptor agonist quinpirole. In A, experiments were performed in the absence (■) or in the presence of the H3 receptor agonists RAMH (●), immepip (○) or imetit (▼) (20 nM in all cases). In C, experiments were performed in the presence of 20 nM RAMH (●) or 20 nM RAMH plus 1 μM thioperamide (△). Data are means ± S.D. from representative experiments performed in triplicate. . (B) Displacement of 1.4 nM [3H] YM-09151-2 binding by 0.1 μM (black bars) or 1 μM (white bars) of the H3 receptor agonists RAMH, immepip or imetit or the H3 receptor antagonist thioperamide. Values are expressed as specific binding percentage respect to the specific binding in absence of H3 receptor ligands. Data are means ± S.E.M. Significant differences were calculated by Student’s t test for unpaired samples (**: p<0.01).